+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Enteral Feeding Formulas Market Size, Share & Industry Trends Analysis Report By End User, By Application (Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes), By Stage, By Product, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 101 Pages
  • August 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5659327
The North America Enteral Feeding Formulas Market is expected to witness market growth of 8.0% CAGR during the forecast period (2022-2028).

A rise in the incidence of malnutrition linked to higher ICU mortality is one of the major causes pushing the adoption of enteral feeding formulas. Despite being a common illness that is commonly ignored and unappreciated globally, malnutrition has a significant death rate in several regions of the world. For instance, malnutrition is thought to be the cause of roughly 45% of fatalities among children under the age of five, with mortality rates being greater in low- and middle-income nations.

Additionally, one of the major factors influencing the market is a rise in product launches and product development by manufacturers. For instance, Victus, Inc. introduced "Abintra Care," a specialized nutritional supplement, in 2020. It contains a blend of important minerals, including vitamin C, antioxidants, zinc, and selenium. This simple-to-use rotating peristaltic pump facilitates the delivery of enteral nutrition. This device is safe and accurate since it has sound and light alarm features to warn the user in the event of a pipeline blockage or low battery voltage.

Due to the widespread use of enteral feeding formula in the region as a result of the high rate of preterm deliveries, North America is a major region in the enteral feeding formulas market. This region is heavily involved in the growing amount of enteral nutrition and mechanism research, development, and technological innovation.

The US market is leading in the North America Enteral Feeding Formulas Market by Country in 2021; thereby, achieving a market value of $2.3 billion by 2028. The Canada market is poised to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The Mexico market is expected to showcase a CAGR of 9.5% during (2022 - 2028).

Based on End User, the market is segmented into Hospitals, Long Term Care facilities, Nursing Homes, Assisted Living Facilities, and Home Care Agencies & Hospices. Based on Application, the market is segmented into Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes, and Others. Based on Stage, the market is segmented into Adults and Pediatric. Based on Product, the market is segmented into Standard Formula, Disease specific, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danone S.A. (Sofina Group), Nestle S.A., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd., Meiji Holdings Co., Ltd., Reckitt Benckiser Group PLC, Hormel Foods Corporation and Medline Industries, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End User
  • Hospitals
  • Long Term Care facilities
  • Nursing Homes
  • Assisted Living Facilities
  • Home Care Agencies & Hospices
By Application
  • Oncology
  • Neurological Disorders
  • Gastrointestinal Diseases
  • Diabetes
  • Others
By Stage
  • Adults
  • Pediatric
By Product
  • Standard Formula
  • Disease specific
  • Diabetic Formula
  • Renal Formula
  • Hepatic Formula
  • Pulmonary Formula
  • Peptide-based Formula
  • Other Disease Specific Formula
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Danone S.A. (Sofina Group)
  • Nestle S.A.
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Meiji Holdings Co., Ltd.
  • Reckitt Benckiser Group PLC
  • Hormel Foods Corporation
  • Medline Industries, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Enteral Feeding Formulas Market, by End User
1.4.2 North America Enteral Feeding Formulas Market, by Application
1.4.3 North America Enteral Feeding Formulas Market, by Stage
1.4.4 North America Enteral Feeding Formulas Market, by Product
1.4.5 North America Enteral Feeding Formulas Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Enteral Feeding Market
Chapter 4. North America Enteral Feeding Formulas Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Long Term Care facilities Market by Country
4.3 North America Nursing Homes Market by Country
4.4 North America Assisted Living Facilities Market by Country
4.5 North America Home Care Agencies & Hospices Market by Country
Chapter 5. North America Enteral Feeding Formulas Market by Application
5.1 North America Oncology Market by Country
5.2 North America Neurological Disorders Market by Country
5.3 North America Gastrointestinal Diseases Market by Country
5.4 North America Diabetes Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Enteral Feeding Formulas Market by Stage
6.1 North America Adults Market by Country
6.2 North America Pediatric Market by Country
Chapter 7. North America Enteral Feeding Formulas Market by Product
7.1 North America Standard Formula Market by Country
7.2 North America Disease specific Market by Country
7.3 North America Diabetic Formula Market by Country
7.4 North America Renal Formula Market by Country
7.5 North America Hepatic Formula Market by Country
7.6 North America Pulmonary Formula Market by Country
7.7 North America Peptide-based Formula Market by Country
7.8 North America Other Disease Specific Formula Market by Country
7.9 North America Others Market by Country
Chapter 8. North America Enteral Feeding Formulas Market by Country
8.1 US Enteral Feeding Formulas Market
8.1.1 US Enteral Feeding Formulas Market by End User
8.1.2 US Enteral Feeding Formulas Market by Application
8.1.3 US Enteral Feeding Formulas Market by Stage
8.1.4 US Enteral Feeding Formulas Market by Product
8.2 Canada Enteral Feeding Formulas Market
8.2.1 Canada Enteral Feeding Formulas Market by End User
8.2.2 Canada Enteral Feeding Formulas Market by Application
8.2.3 Canada Enteral Feeding Formulas Market by Stage
8.2.4 Canada Enteral Feeding Formulas Market by Product
8.3 Mexico Enteral Feeding Formulas Market
8.3.1 Mexico Enteral Feeding Formulas Market by End User
8.3.2 Mexico Enteral Feeding Formulas Market by Application
8.3.3 Mexico Enteral Feeding Formulas Market by Stage
8.3.4 Mexico Enteral Feeding Formulas Market by Product
8.4 Rest of North America Enteral Feeding Formulas Market
8.4.1 Rest of North America Enteral Feeding Formulas Market by End User
8.4.2 Rest of North America Enteral Feeding Formulas Market by Application
8.4.3 Rest of North America Enteral Feeding Formulas Market by Stage
8.4.4 Rest of North America Enteral Feeding Formulas Market by Product
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Danone S.A. (Sofina Group)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Recent strategies and developments:
9.2.3.1 Acquisition and Mergers:
9.3 Nestle S.A.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 Fresenius SE & Co. KGaA
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Approvals and Trails:
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.6 Otsuka Pharmaceutical Co., Ltd.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Product Launches and Product Expansions:
9.7 Meiji Holdings Co., Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 Research & Development Expense
9.8 Reckitt Benckiser Group PLC
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.9 Hormel Foods Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental Analysis
9.9.4 Research & Development Expenses
9.10. Medline Industries, Inc.
9.10.1 Company Overview

Companies Mentioned

  • Abbott Laboratories
  • Danone S.A. (Sofina Group)
  • Nestle S.A.
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Meiji Holdings Co., Ltd.
  • Reckitt Benckiser Group PLC
  • Hormel Foods Corporation
  • Medline Industries, Inc.

Methodology

Loading
LOADING...